1. Wilke A, Wende C, Horst M, Steverding D: Thrombosis of a prosthetic mitral valve after
withdrawal of phenprocoumon therapy. Cardiol Res 2011 (in print)
2. Diepholz D, Wilke A, Maisch B, Steverding D: Demonstration of TGF- β and XIII α
in Endocardial Biopsies of Carcinoid Heart Disease Patients: an Immunofluorescence Study. Cardiol Res 2011;2(3):119-122
3. Wilke A, Steverding D: Does the Cardiologist play a Key Role in the Management of
Hypertension? Cardiol Res 2011;2(2):79-81
4. Wilke A, Dapunt O, Steverding D: Bluish Pigmentation of the Sclera and the Aortic
Valve in a Patient with Alkaptonuric Ochronosis. Herz. 2010 Jan;35(1):41
5. Wilke A, Steverding D: Ochronosis as an unusual cause of valvular defect: a case report. J
6. Schuchert A, Rebeski HP, Peiffer T, Bub E, Dietz A, Mortensen K, Aydin MA, Camm J,
Gazarek S, Meinertz T; Leonhardt V, Ebner E, Hartung W, Schneider W, Wilke A,
Müller M, Lang A, Schwerdt RC, Schöning F.: Effects of continuous and triggered atrial
overdrive pacing on paroxysmal atrial fibrillation in pacemaker patients; Pacing Clin
7. Portig I, Wilke A, Freyland M, Wolf MJ, Richter A, Ruppert V, Pankuweit S, Maisch B;.;
Familial inflammatory dilated cardiomyopathy; Eur J Heart Fail. 2006 Dec;8(8):816-25
8. Diepholz D, Stuhn-Pfeifer HJ, Wilke A: An unusual reason for a diastolic murmur. Herz.
9. Wilke A, Noll B, Maisch B.;Recurrent ventricular fibrillation after defibrillation in a
patient with pacemaker;Med Klin (Munich). 2000 Sep 15;95(9):523-6.
10. Wilke A, Noll B, Maisch B.;Angina pectoris in extracoronary diseases;Herz. 1999
11. Wilke A, Kruse T, Hesse H, Funck R, Maisch B.;Risk of interference between
pacemakers and security systems.;Pacing Clin Electrophysiol. 1999 Mar;22(3):540
12. Mestroni L, Maisch B, McKenna WJ, Schwartz K, Charron P, Rocco C, Tesson F,
Richter A, Wilke A, Komajda M.;Guidelines for the study of familial dilated
cardiomyopathies. Collaborative Research Group of the European Human and Capital
Mobility Project on Familial Dilated Cardiomyopathy;Eur Heart J. 1999 Jan;20(2):93-102.
13. Wilke A, Hesse H, Gorg C, Maisch B.;Elevation of the pacing threshold: a side effect in a
patient with pacemaker undergoing therapy with doxorubicin and vincristine.;Oncology.
14. Wilke A, Maisch B.;Sources of interference for cardiac pacemakers. Technical
improvements of pacemakers--risks in the medical realm;Fortschr Med. 1998 Aug
15. Wilke A, Kruse T, Maisch B.;Angina pectoris in leiomyoma;Herz. 1998 Aug;23(5):299-
16. Wilke A, Kruse T, Hesse H, Funck R, Maisch B.;Interactions between pacemakers and
security systems.;Pacing Clin Electrophysiol. 1998 Sep;21(9):1784-8
17. Wilke A, Kruse T, Hesse H, Bittinger A, Moosdorf R, Maisch B.;Papillary muscle injury
after blunt chest trauma.;J Trauma. 1997 Aug;43(2):360-1
18. Wilke A, Kruse T, Funck R, Maisch B.;Risk factors for pacemaker disorders;Dtsch Med
19. Wilke A, Hesse H, Hufnagel G, Maisch B.;Mitral, aortic and tricuspid valvular heart
disease associated with ergotamine therapy for migraine.;Eur Heart J. 1997 Apr;18(4):701
20. Funck RC, Wilke A, Rupp H, Brilla CG.;Regulation and role of myocardial collagen
matrix remodeling in hypertensive heart disease.;Adv Exp Med Biol. 1997;432:35-44
21. Wilke A, Grimm W, Funck R, Maisch B.;Influence of D-net (European GSM-Standard)
cellular phones on pacemaker function in 50 patients with permanent pacemakers.;Pacing
Clin Electrophysiol. 1996 Oct;19(10):1456-8
22. Wilke A, Kaiser A, Ferency I, Maisch B.;Alcohol and myocarditis;Herz. 1996
23. Wilke A, Funck R, Rupp H, Brilla CG.;Effect of the renin-angiotensin-aldosterone
system on the cardiac interstitium in heart failure.;Basic Res Cardiol. 1996;91 Suppl 2:79-
24. Funck RC, Wilke A, Rupp H, Maisch B, Brilla CG.;Cardiac structure-function
relationship and the renin-angiotensin-aldosterone system in hypertensive heart
25. Wilke A, Grimm W, Kohler H, Maisch B.;Differential diagnostic challenge in pericardial
effusion;Internist (Berl). 1995 Sep;36(9):909-11
26. Wilke A, Schonian U, Herzum M, Hengstenberg C, Hufnagel G, Brilla CG, Maisch
B.;The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory
27. Wilke A, Schmoll J.;Typical complications of short rib polydactyly syndrome;Klin Padiatr.
This leaflet is to help you recognise when you are having a flare up of your COPD/bronchitis. Earlytreatment of flare ups can reduce your chance of going to hospital. Flare ups start with either a changein your sputum or a worsening of your breathlessness. If this happens, follow the instructions below. IF AT ANY TIME YOU ARE UNSURE WHAT TO DO, PLEASE CONTACT YOUR PRACTICE NURSE, DELMA HEA
André Seidenberg , Dr.med. LEGAL ABORTION BY MEDICATION Emergency call: +41 44 266 58 03 Abortion by medicaments is an outpatient treatment. You may stay at home or in our medical practice. Up to 7 weeks after the beginning of the last menstrual bleeding, abortion induced by the following two medicaments is the methode of choice: Mifegyn® (Mifepriston or RU486) blo